Skip to main content

Organovo Holdings, Inc. (ONVO)

NASDAQ: ONVO · IEX Real-Time Price · USD
6.07
-0.06 (-0.98%)
After-hours:Oct 22, 2021 7:31 PM EDT
6.13
-0.06 (-0.97%)
At close: Oct 22, 4:00 PM

Company Description

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases.

The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Organovo Holdings, Inc.
Organovo Holdings Logo
CountryUnited States
Founded2007
IndustryBiotechnology
SectorHealth Care
Employees9

Contact Details

Address:
440 Stevens Avenue
Solana Beach, CA 92075
United States
Phone858 224 1000
Websiteorganovo.com

Stock Details

Ticker SymbolONVO
ExchangeNASDAQ
Fiscal YearApril - March
Reporting CurrencyUS Dollars
CIK Code0001497253
CUSIP Number62620A104
ISIN NumberUS68620A2033
Employer ID27-1488943

Key Executives

NamePosition
Keith E. MurphyExecutive Chairman and Principal Executive Officer
Dr. Jeffrey N. MinerChief Scientific Officer
Thomas Einar Jurgensen J.D., MSGeneral Counsel and Corporate Secretary
Thomas P. Hess CPA, MBAPresident and Chief Financial Officer
Steve E. KunszaboVice President of Investor Relations and Corporate Communications